Literature DB >> 29696788

Delayed peak response of cortisol to insulin tolerance test in patients with Prader-Willi syndrome.

Yuji Oto1, Keiko Matsubara2, Tadayuki Ayabe2, Masahisa Shiraishi1, Nobuyuki Murakami1, Hiroshi Ihara3, Tomoyo Matsubara1, Toshiro Nagai4.   

Abstract

Deaths among children with Prader-Willi syndrome (PWS) are often related to only mild or moderate upper respiratory tract infections, and many causes of death remain unexplained. Several reports have hypothesized that patients with PWS may experience latent central adrenal insufficiency. However, whether PWS subjects suffer from alteration of the hypothalamus-pituitary-adrenal (HPA) axis remains unclear. This study aimed to explore the HPA axis on PWS. We evaluated the HPA axis in 36 PWS patients (24 males, 12 females; age range, 7 months to 12 years; median age 2.0 years; interquartile range [IQR], 1.5-3.4 years) using an insulin tolerance test (ITT) in the morning between 08:00 and 11:00. For comparison, ITT results in 37 age-matched healthy children evaluated for short stature were used as controls. In PWS patients, basal levels of adrenocorticotropic hormone (ACTH) were 13.5 pg/ml (IQR, 8.3-27.5 pg/ml) and basal levels of cortisol were 18.0 μg/dl (IQR, 14.2-23.7 μg/dl). For all patients, cortisol levels at 60 min after stimulation were within the reference range (>18.1 μg/dl), with a median peak of 41.5 μg/dl (IQR, 32.3-48.6 μg/dl). Among control children, basal level of ACTH and basal and peak levels of cortisol were 10.9 (IQR, 8.5-22.0 pg/ml), 15.6 (IQR, 11.9-21.6 μg/dl), and 27.8 μg/dl (IQR, 23.7-30.5 μg/dl), respectively. Basal and peak levels of cortisol were all within normal ranges, but peak response of cortisol to ITT was delayed in the majority of PWS patients (64%). Although the mechanism remains unclear, this delay may signify the existence of central obstacle in adjustment of the HPA axis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Prader-Willi syndrome; central adrenal insufficiency; delayed peak response

Mesh:

Substances:

Year:  2018        PMID: 29696788     DOI: 10.1002/ajmg.a.38713

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

Review 1.  Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.

Authors:  Merlin G Butler; Jennifer L Miller; Janice L Forster
Journal:  Curr Pediatr Rev       Date:  2019

Review 2.  Requirements for improving health and well-being of children with Prader-Willi syndrome and their families.

Authors:  Jessica Mackay; Zoe McCallum; Geoffrey R Ambler; Komal Vora; Gillian Nixon; Philip Bergman; Nora Shields; Kate Milner; Nitin Kapur; Patricia Crock; Daan Caudri; Jaqueline Curran; Charles Verge; Chris Seton; Andrew Tai; Elaine Tham; Yassmin Musthaffa; Antony R Lafferty; Greg Blecher; Jessica Harper; Cara Schofield; Aleisha Nielsen; Andrew Wilson; Helen Leonard; Catherine S Choong; Jenny Downs
Journal:  J Paediatr Child Health       Date:  2019-06-30       Impact factor: 1.954

3.  Prader-Willi syndrome: an update on obesity and endocrine problems.

Authors:  Su Jin Kim; Sung Yoon Cho; Dong-Kyu Jin
Journal:  Ann Pediatr Endocrinol Metab       Date:  2021-12-31

4.  Central Adrenal Insufficiency Is Rare in Adults With Prader-Willi Syndrome.

Authors:  Anna G W Rosenberg; Karlijn Pellikaan; Christine Poitou; Anthony P Goldstone; Charlotte Høybye; Tania Markovic; Graziano Grugni; Antonino Crinò; Assumpta Caixàs; Muriel Coupaye; Sjoerd A A Van Den Berg; Aart Jan Van Der Lely; Laura C G De Graaff
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

5.  Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory.

Authors:  Juliette Salles; Sanaa Eddiry; Emmanuelle Lacassagne; Virginie Laurier; Catherine Molinas; Éric Bieth; Nicolas Franchitto; Jean-Pierre Salles; Maithé Tauber
Journal:  Clin Epigenetics       Date:  2021-08-13       Impact factor: 6.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.